SCHEMBL7359765

SCHEMBL7359765

O=C1OCC=C1Cc1ccc2ccccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTRC Q99895 1/20 0.46
NQO1 P15559 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2A6 P11509 1/20 0.42
CYP2D6 P10635 1/20 0.41
NFKB1 P19838 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
TBXA2R P21731 1/20 0.40
PTGER4 P35408 1/20 0.40
PTGFR P43088 1/20 0.40
PTGER3 P43115 1/20 0.40
PTGER2 P43116 1/20 0.40
PTGDR Q13258 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRB2 P47870 1/20 0.40
BACE1 P56817 1/20 0.40
ALOX5 P09917 1/20 0.40
NAAA Q02083 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7565723 0.76 FAAH (0.44) NAAA
SCHEMBL2838141 0.72 CYP1A2 (0.65) CTRCCYP1A2CYP2A6CYP2D6NFKB1
SCHEMBL4574327 0.69 NQO1 (0.46) CTRCNQO1CYP1A2CYP2A6CYP2D6
SCHEMBL5900962 0.68 CYP1A2 (0.60) CTRCCYP1A2CYP2A6CYP2D6NFKB1
SCHEMBL28846677 0.68 CYP1A2 (0.60) CTRCCYP1A2CYP2A6CYP2D6NFKB1
SCHEMBL30527823 0.68 GSTP1 (0.48) CYP1A2GABRA1GABRG2GABRB3ALOX5
SCHEMBL8551301 0.68 GSTP1 (0.48) CYP1A2GABRA1GABRG2GABRB3ALOX5
SCHEMBL9595621 0.67 CYP1A2 (0.54) CTRCCYP1A2CYP2A6CYP2D6NFKB1
SCHEMBL29417927 0.67 CYP1A2 (0.58) CYP1A2CYP2A6CYP2D6NFKB1TAAR1
SCHEMBL598561 0.67 CYP1A2 (0.58) CYP1A2CYP2A6CYP2D6NFKB1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376539-B1 ANTIISCHEMIC AGENTS, CENTRAL NERVOUS SYSTEM DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 2002-04-23 US disclosed
EP-1047686-A1 SUBSTITUTED BICYCLIC LACTONES Bayer Aktiengesellschaft (DE) 2000-11-02 EP disclosed
WO-1999036418-A1 SUBSTITUTED BICYCLIC LACTONES BAYER AKTIENGESELLSCHAFT (DE) 1999-07-22 WO disclosed